Vesselon: Novel Solutions to Oncology’s Biggest Problems

We Break the Oncology Sound Barrier

We solve the biggest problems facing many oncology drugs: toxicity, degradation, and limited immune response.

Our acoustically active drugs lead to breakthrough clinical solutions.


Our Acoustically Active Drugs Make Tissue Permeable, Changing How Cancer is Treated

The expansion and contraction of the vessel wall from lipid microspheres under low intensity ultrasound (“stable cavitation”) opens pores to allow more drugs to get into the tumor: "Sonoporation"

Regulatory De-Risk

All components of our platform are FDA approved or cleared and have been commercially used in humans.

See where our drugs can help

Endless Stream of Proprietary
Acoustically Active Drugs

Vesselon has a scalable pharmacology platform where we take off-patent, licensed, or novel drugs and create acoustically active conjugates to make them better for new or existing indications.